Original Research
Published on 11 Nov 2025
Engineered NK92 cell-derived exosomes inhibit ovarian cancer progression by degrading GPRC5A
in Cancer Immunity and Immunotherapy
- 790 views
Original Research
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 11 Nov 2025
in Epilepsy
Original Research
Published on 11 Nov 2025
in Aging and Public Health
Original Research
Published on 11 Nov 2025
in Cultural Psychology
Opinion
Published on 11 Nov 2025
in Autism
Original Research
Published on 11 Nov 2025
in B Cell Biology
Original Research
Published on 11 Nov 2025
in Digital Mental Health
Original Research
Published on 11 Nov 2025
in Sport Psychology
Original Research
Published on 11 Nov 2025
in Environment, Politics and Society
General Commentary
Published on 11 Nov 2025
in Veterinary and Zoonotic Infection
Original Research
Published on 11 Nov 2025
in Life-Course Epidemiology and Social Inequalities in Health
Case Report
Published on 11 Nov 2025
in Pediatric Hematology and Hematological Malignancies
Case Report
Published on 11 Nov 2025
in Genitourinary Oncology
Community Case Study
Published on 11 Nov 2025
in Special Educational Needs
Editorial
Published on 11 Nov 2025
in Nanobiotechnology
Review
Published on 11 Nov 2025
in Immunological Tolerance and Regulation